share_log

醫渡科技:截至二零二四年三月三十一日止股份發行人的證券變動月報表

YIDU TECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 8 07:06
Summary by Moomoo AI
醫渡科技有限公司於2024年4月8日向香港交易及結算所有限公司提交了截至2024年3月31日的證券變動月報表。報告顯示,公司的法定/註冊股本維持不變,為2,500,000,000股,每股面值0.00002美元,總額50,000美元。在已發行股份變動方面,公司通過股份期權計劃於本月內增加了8,636,120股普通股,並獲得了4,832.8港元的資金。此外,公司確認所有新發行的證券均已獲得董事會的正式授權和批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
醫渡科技有限公司於2024年4月8日向香港交易及結算所有限公司提交了截至2024年3月31日的證券變動月報表。報告顯示,公司的法定/註冊股本維持不變,為2,500,000,000股,每股面值0.00002美元,總額50,000美元。在已發行股份變動方面,公司通過股份期權計劃於本月內增加了8,636,120股普通股,並獲得了4,832.8港元的資金。此外,公司確認所有新發行的證券均已獲得董事會的正式授權和批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on 8 April 2024 with Hong Kong Trading and Settlement Holdings Limited its Monthly Securities Change Report for the year ended 31 March 2024. The report showed that the company's regulated/registered share capital remained unchanged at 2,500,000,000 shares with a face value of $0.00002 per share for a total of $50,000. In terms of changes in issued shares, the company added 8,636,120 shares of ordinary shares through the share option scheme during the month and received funding of HK$4,832.8. In addition, the Company confirms that all newly issued securities have been formally authorized and approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on 8 April 2024 with Hong Kong Trading and Settlement Holdings Limited its Monthly Securities Change Report for the year ended 31 March 2024. The report showed that the company's regulated/registered share capital remained unchanged at 2,500,000,000 shares with a face value of $0.00002 per share for a total of $50,000. In terms of changes in issued shares, the company added 8,636,120 shares of ordinary shares through the share option scheme during the month and received funding of HK$4,832.8. In addition, the Company confirms that all newly issued securities have been formally authorized and approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more